Clinical Trial Update: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior Anti-TNF Therapy (RESET) [Phase 3]

View source ↗

Summary

A Phase 3 trial update (RESET) of Rituximab (MabThera) in rheumatoid arthritis patients who failed one prior anti-TNF therapy; the study is completed and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• MabThera (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2014-08-05